32 results
Thumbnail

D3.364 - Effect of Omalizumab on Inflammatory and Immune Biomarkers in Mast Cell-Mediated Angioedema

Thumbnail

D3.358 - The impact of limited access to On-Demand Treatment for Hereditary Angioedema on Quality of life: a comparison between two income settings

Thumbnail

D3.359 - Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment

Thumbnail

D3.362 - Use and safety of canakinumab during pregnancy

Thumbnail

D3.363 - Vitamin D3 deficiency promotes epithelial-to-mesenchymal transition and thus favours pulmonary fibrosis development in the murine model of hypersensitivity pneumonitis

Thumbnail

D3.365 - The role of anosmia in predicting biologic responsiveness for Chronic Rhinosinusitis with Nasal Polyposis

Thumbnail

D3.366 - Exploring potential predictive factors for time to response to Omalizumab treatment in a Romanian subset of patients with Chronic Spontaneous Urticaria

Thumbnail

D3.367 - Mental health, sexual functionality, quality of life, and patient experiences with chronic rhinosinusitis with nasal polyps at UNIMEQ-ORL in Bogotá, Colombia, 2022-2024: a mixed-methods study

Thumbnail

D3.368 - Analysis of discontinuation of omalizumab in patients with chronic spontaneous and/or inducible urticaria in a tertiary hospital in one year

Thumbnail

D3.373 - Hives and hidden codes: detection of miRNA in chronic spontaneous urticaria patients - pilot study

Thumbnail

D3.369 - Childhood exhaled nitric oxide levels predict new-onset allergic rhinitis in adolescence and young adulthood

Thumbnail

D3.370 - Inverse Association between Mitochondrial DNA Copy Number and Atopic Dermatitis in Schoolchildren

Thumbnail

D3.371 - Impact of sensitization to main allergen molecules during childhood on adult asthma, atopic dermatitis, rhinitis and food allergy in the BAMSE cohort

Thumbnail

D3.372 - SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps

Thumbnail

D3.374 - Assessment of leukotriene E4 as a long term marker of inflammation between regular maintenance (36 weeks therapy) versus as-needed intranasal corticosteroid use in pediatric allergic rhinitis

Thumbnail

D3.375 - The impact of strontium exposure on allergic rhinitis development via IRE1-mediated protein expression: ECHO-COCOA study

Thumbnail

D3.376 - The severity of the dyspnea and symptom components of COPD determines the disease course

Thumbnail

D3.377 - Eosinophil-derived neurotoxin measured in nasal mucosal lining fluid (Nasosorption) is a promising type 2 biomarker in allergic rhinitis

Thumbnail

D3.378 - Long Covid in epithelial barrier type2 disease: an Italian experience

Thumbnail

D3.379 - Allergen sensitization as a One Health approach: computational IgE clustering in a large cohort of dogs to resolve exposure profiles across Europe